197 related articles for article (PubMed ID: 30281608)
21. Development of two antibody detection enzyme-linked immunosorbent assays for serodiagnosis of human chronic fascioliasis.
Cabán-Hernández K; Gaudier JF; Ruiz-Jiménez C; Espino AM
J Clin Microbiol; 2014 Mar; 52(3):766-72. PubMed ID: 24353000
[TBL] [Abstract][Full Text] [Related]
22. [Evaluation of an ELISA test with Fasciola hepatica metabolic antigen for diagnosis of human fascioliasis in Cajamarca, Peru].
Cornejo H; Oblitas F; Cruzado S; Quispe W
Rev Peru Med Exp Salud Publica; 2010; 27(4):569-74. PubMed ID: 21308197
[TBL] [Abstract][Full Text] [Related]
23. [Indirect ultra-micro-ELISA for detecting IgG antibodies in patients with fascioliasis].
Espino AM; Padrón L; Duménigo B; Laferté J
Rev Cubana Med Trop; 1997; 49(3):167-73. PubMed ID: 9685983
[TBL] [Abstract][Full Text] [Related]
24. Diagnosis of fasciolosis antibodies in Brazilian cattle through ELISA employing both native and recombinant antigens.
Drescher G; Dos Santos HG; Pinto MMdG; Morello LG; Figueiredo FB
Microbiol Spectr; 2024 May; 12(5):e0009524. PubMed ID: 38534120
[TBL] [Abstract][Full Text] [Related]
25. Immunodiagnosis of human fascioliasis by an enzyme-linked immunosorbent assay (ELISA) and a micro-ELISA.
Carnevale S; Rodríguez MI; Santillán G; Labbé JH; Cabrera MG; Bellegarde EJ; Velásquez JN; Trgovcic JE; Guarnera EA
Clin Diagn Lab Immunol; 2001 Jan; 8(1):174-7. PubMed ID: 11139214
[TBL] [Abstract][Full Text] [Related]
26. Development of Two FhSAP2 Recombinant-Based Assays for Immunodiagnosis of Human Chronic Fascioliasis.
Shin SH; Hsu A; Chastain HM; Cruz LA; Elder ES; Sapp SG; McAuliffe I; Espino AM; Handali S
Am J Trop Med Hyg; 2016 Oct; 95(4):852-855. PubMed ID: 27549636
[TBL] [Abstract][Full Text] [Related]
27. A new method for serodiagnosis of sheep fascioliasis using helminth excretory-secretory products.
Bautista-Garfias CR; López-Arellano ME; Sánchez-Albarrán A
Parasitol Res; 1989; 76(2):135-7. PubMed ID: 2515538
[TBL] [Abstract][Full Text] [Related]
28. Design and expression of polytopic construct of cathepsin-L1, SAP-2 and FhTP16.5 proteins of
Aghamolaei S; Kazemi B; Bandehpour M; Ranjbar MM; Rouhani S; Javadi Mamaghani A; Tabaei SJS
J Helminthol; 2020 Mar; 94():e134. PubMed ID: 32127056
[TBL] [Abstract][Full Text] [Related]
29. Short report: Immunodiagnosis of human fascioliasis using recombinant Fasciola hepatica cathepsin L1 cysteine proteinase.
O'Neill SM; Parkinson M; Dowd AJ; Strauss W; Angles R; Dalton JP
Am J Trop Med Hyg; 1999 May; 60(5):749-51. PubMed ID: 10344647
[TBL] [Abstract][Full Text] [Related]
30. Lack of protective efficacy in buffaloes vaccinated with Fasciola gigantica leucine aminopeptidase and peroxiredoxin recombinant proteins.
Raina OK; Nagar G; Varghese A; Prajitha G; Alex A; Maharana BR; Joshi P
Acta Trop; 2011 Jun; 118(3):217-22. PubMed ID: 21376699
[TBL] [Abstract][Full Text] [Related]
31. Immunodiagnosis of human fascioliasis with Fasciola hepatica cysteine proteinases.
Córdova M; Reátegui L; Espinoza JR
Trans R Soc Trop Med Hyg; 1999; 93(1):54-7. PubMed ID: 10492791
[TBL] [Abstract][Full Text] [Related]
32. Detection of circulating excretory secretory antigens in human fascioliasis by sandwich enzyme-linked immunosorbent assay.
Espino AM; Marcet R; Finlay CM
J Clin Microbiol; 1990 Dec; 28(12):2637-40. PubMed ID: 2279994
[TBL] [Abstract][Full Text] [Related]
33. Design and synthesis of a new peptide derived from Fasciola gigantica cathepsin L1 with potential application in serodiagnosis of fascioliasis.
Meshgi B; Jalousian F; Fathi S; Jahani Z
Exp Parasitol; 2018 Jun; 189():76-86. PubMed ID: 29679594
[TBL] [Abstract][Full Text] [Related]
34. Characterization and differential expression of a ferritin protein from Fasciola hepatica.
Cabán-Hernández K; Gaudier JF; Espino AM
Mol Biochem Parasitol; 2012; 182(1-2):54-61. PubMed ID: 22240114
[TBL] [Abstract][Full Text] [Related]
35. [Fecal antigens of Fasciola hepatica potentially useful in the diagnosis of fascioliasis].
Espino AM; B2rges A; Duménigo BE
Rev Panam Salud Publica; 2000 Apr; 7(4):225-31. PubMed ID: 10846925
[TBL] [Abstract][Full Text] [Related]
36. Design of a Peptide-Carrier Vaccine Based on the Highly Immunogenic Fasciola hepatica Leucine Aminopeptidase.
Salazar C; Tort JF; Carmona C
Methods Mol Biol; 2020; 2137():191-204. PubMed ID: 32399930
[TBL] [Abstract][Full Text] [Related]
37. The use of MM3 monoclonal antibodies for the early immunodiagnosis of ovine fascioliasis.
Mezo M; González-Warleta M; Ubeira FM
J Parasitol; 2007 Feb; 93(1):65-72. PubMed ID: 17436943
[TBL] [Abstract][Full Text] [Related]
38. Evaluation of immunoglobulin G4 subclass antibody in a peptide-based enzyme-linked immunosorbent assay for the serodiagnosis of human fascioliasis.
Tantrawatpan C; Maleewong W; Wongkham C; Wongkham S; Intapan PM; Nakashima K
Parasitology; 2007 Dec; 134(Pt.14):2021-6. PubMed ID: 17714604
[TBL] [Abstract][Full Text] [Related]
39. Vaccine potential of recombinant saposin-like protein 2 against Fasciolosis gigantica in mice.
Kueakhai P; Changklungmoa N; Riengrojpitak S; Chaichanasak P; Meemon K; Chaithirayanon K; Chantree P; Sansri V; Itagaki T; Sobhon P
Vaccine; 2013 Nov; 31(47):5518-23. PubMed ID: 24075921
[TBL] [Abstract][Full Text] [Related]
40. Antigenic components of excretory-secretory products of adult Fasciola hepatica recognized in human infections.
Sampaio-Silva ML; Da Costa JM; Da Costa AM; Pires MA; Lopes SA; Castro AM; Monjour L
Am J Trop Med Hyg; 1996 Feb; 54(2):146-8. PubMed ID: 8619438
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
